(Q40476936)

20 September 2017

Anti-Jo-1 antibody positive polymyositis--successful therapy with leflunomide. (English)

1 reference

20 September 2017

0 references

1 reference

ChEBI release 2020-05-28

3

Ulf Müller-Ladner

1 reference

20 September 2017

Uwe Lange

1

1 reference

20 September 2017

Manfred Piegsa

series ordinal

2

1 reference

20 September 2017

Johannes Strunk

series ordinal

4

1 reference

20 September 2017

language of work or name

1 reference

1 May 2006

1 reference

20 September 2017

1 reference

20 September 2017

39

1 reference

20 September 2017

3

1 reference

20 September 2017

261-264

1 reference

Autoimmune muscular pathologies

20 September 2017

1 reference

https://api.crossref.org/works/10.1080%2F08916930600623874

Outcomes and disease activity measures for assessing treatments in the idiopathic inflammatory myopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600623874

Malignancy in patients with inflammatory myopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600623874

Update on myositis-specific and myositis-associated autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600623874

Familial inflammatory inclusion body myositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600623874

Efficacy and safety of leflunomide 10 mg versus 20 mg once daily in patients with active rheumatoid arthritis: multinational double-blind, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600623874

Leflunomide in rheumatoid arthritis: recommendations through a process of consensus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600623874

Benefits of leflunomide in systemic lupus erythematosus: a pilot observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600623874

Maintenance of remission with leflunomide in Wegener's granulomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600623874

Polymyositis-dermatomyositis and malignant lesions: does an association exist?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600623874

Treatment and investigation of idiopathic inflammatory myopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600623874

The effectiveness of treating juvenile dermatomyositis with methotrexate and aggressively tapered corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600623874

Treatment of corticosteroid-resistant polymyositis with methotrexate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600623874

Prednisone and azathioprine for polymyositis: long-term followup.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600623874

Cyclosporin in the management of polymyositis and dermatomyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600623874

Intravenous pulse cyclophosphamide therapy in myositis and Sjögren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600623874

Efficacy of intravenous gammaglobulin therapy in chronic refractory polymyositis and dermatomyositis: An open study with 20 adult patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600623874

Results and long-term followup of intravenous immunoglobulin infusions in chronic, refractory polymyositis: an open study with thirty-five adult patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600623874

Anti-Sm and anti-RNP antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600623874

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600623874

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600623874

The long-term outcome of anti-Jo-1-positive inflammatory myopathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600623874

Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis

21 January 2018

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD003643.PUB2

Identifiers

DOI

10.1080/08916930600623874

1 reference

20 September 2017

1 reference